Patient Preferences in the Treatment of NSCLC

Lara Kujtan, assistant professor at the 海角论坛 School of Medicine, discusses its importance
about the importance of patient preferences in the treatment of oncogene-driven non-small cell lung cancer (NSCLC).

Published: Jan 22, 2019